Drug Benefit List 2010
10:00 ANTINEOPLASTIC AGENTS
10:00.00 ANTINEOPLASTIC AGENTS
ALTRETAMINE
- 50mg Capsule
- 2126230 HEXALEN LIL
ANASTROZOLE
- 1mg Tablet
- 2224135 ARIMIDEX AZC
BICALUTAMIDE
- 50mg Tablet
- 2296063 APO-BICALUTAMIDE APX
- 2184478 CASODEX AZC
- 2274337 CO BICALUTAMIDE COB
- 2302403 GEN-BICALUTAMIDE GEN
- 2270226 NOVO-BICALUTAMIDE NOP
- 2275589 PMS-BICALUTAMIDE PMS
- 2311038 PRO-BICALUTAMIDE PDL
- 2277700 RATIO-BICALUTAMIDE RPH
- 2276089 SANDOZ-BICALUTAMIDE SDZ
BUSERELIN ACETATE
- 1mg/mL Injection
- 2225166 SUPREFACT SAC
- 1mg/mL Nasal Solution
- 2225158 SUPREFACT SAC
- 6.3mg/Implant Subcutaneous Injection
- 2228955 SUPREFACT DEPOT 2 MONTHS SAC
- 9.45mg/Implant Subcutaneous Injection
- 2240749 SUPREFACT DEPOT 3 MONTHS SAC
BUSULFAN
- 2mg Tablet
- 4618 MYLERAN GSK
CAPECITABINE
- 150mg Tablet
- 2238453 XELODA HLR
- 500mg Tablet
- 2238454 XELODA HLR
CHLORAMBUCIL
- 2mg Tablet
- 4626 LEUKERAN GSK
CYCLOPHOSPHAMIDE
- 25mg Tablet
- 2241795 PROCYTOX BAT
- 50mg Tablet
- 344885 CYTOXAN BMS
- 2241796 PROCYTOX BAT
CYPROTERONE ACETATE
- 50mg Tablet
- 704431 ANDROCUR BEX
- 2245898 APO-CYPROTERONE APX
- 2229723 GEN-CYPROTERONE GEN
ERLOTINIB HYDROCLORIDE
Limited use benefit (prior approval required).
Treatment of non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen, and whose EGFR expression status is positive or unknown.
- 100mg Tablet
- 2269015 TARCEVA HLR
- 150mg Tablet
- 2269023 TARCEVA HLR
ETOPOSIDE
- 50mg Capsule
- 616192 VEPESID BMS
EXEMESTANE
- 25mg Tablet
- 2242705 AROMASIN PFI
FLUDARABINE PHOSPHATE
- 10mg Tablet
- 2246226 FLUDARA BEX
FLUTAMIDE
- 250mg Tablet
- 2238560 APO-FLUTAMIDE APX
- 637726 EUFLEX SCH
- 2230089 NOVO-FLUTAMIDE NOP
- 2239388 PDL-FLUTAMIDE PDL
- 2230104 PMS-FLUTAMIDE PMS
GOSERELIN ACETATE
- 3.6mg/Depot Injection
- 2049325 ZOLADEX AZC
- 10.8mg/Depot Injection
- 2225905 ZOLADEX LA AZC
HYDROXYUREA
- 500mg Capsule
- 2247937 APO-HYDROXYUREA APX
- 2242920 GEN-HYDROXYUREA GEN
- 500mg Tablet
- 465283 HYDREA BMS
IMATINIB MESYLATE
Limited use benefit (prior approval required).
- For the treatment of patients with chronic myeloid leukemia in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.
- For the treatment of patients with gastrointestinal stromal tumour.
- For newly diagnosed adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML).
- 100mg Tablet
- 2253275 GLEEVEC NVR
- 400mg Tablet
- 2253283 GLEEVEC NOV
INTERFERON ALFA-2B
- 6,000,000IU/mL Injection
- 2238674 INTRON A SCH
- 10,000,000IU/mL Injection
- 2238675 INTRON A SCH
- 10,000,000IU/Vial Injection
- 2223406 INTRON A SCH
- 15,000,000IU/mL Injection
- 2240693 INTRON A SCH
- 18,000,000IU/Vial Injection
- 2231651 INTRON A SCH
- 25,000,000IU/mL Injection
- 2240694 INTRON A SCH
- 50,000,000IU/mL Injection
- 2240695 INTRON A SCH
LETROZOLE
- 2.5mg Tablet
- 2231384 FEMARA NVR
- 2348969 LETROZOLE CBT
- 2309114 PMS-LETROZOLE PMS
- 2344815 SANDOZ LETROZOLE SDZ
LEUPROLIDE ACETATE
- 3.75mg/Vial Injection
- 884502 LUPRON DEPOT ABB
- 7.5mg/Vial Injection
- 836273 LUPRON DEPOT ABB
- 11.25mg/Vial Injection
- 2239834 LUPRON DEPOT ABB
- 22.5mg/Vial Injection
- 2248240 ELIGARD SAC
- 2230248 LUPRON DEPOT ABB
- 30mg/Vial Injection
- 2248999 ELIGARD SAC
- 2239833 LUPRON DEPOT ABB
- 45mg/Vial Injection
- 2268892 ELIGARD SAC
LOMUSTINE
- 10mg Capsule
- 360430 CEENU BMS
LOMUSTINE
- 40mg Capsule
- 360422 CEENU BMS
- 100mg Capsule
- 360414 CEENU BMS
MEGESTROL ACETATE
- 40mg/mL Suspension
- 2168979 MEGACE BMS
- 40mg Tablet
- 2195917 APO-MEGESTROL APX
- 2223104 MEGESTROL PDL
- 2185415 NU-MEGESTROL NXP
- 160mg Tablet
- 2195925 APO-MEGESTROL APX
- 731323 MEGACE BMS
- 2223112 MEGESTROL PDL
- 2185423 NU-MEGESTROL NXP
MELPHALAN
- 2mg Tablet
- 4715 ALKERAN GSK
MERCAPTOPURINE
- 50mg Tablet
- 4723 PURINETHOL NOP
METHOTREXATE SODIUM
- 10mg/mL Injection
- 2182947 METHOTREXATE MAY
- 25mg/mL Injection
- 2182777 METHOTREXATE MAY
- 2182955 METHOTREXATE MAY
- 2099705 NOVO-METHOTREXATE NOP
- 2.5mg Tablet
- 2182963 APO-METHOTREXATE APX
- 2170698 METHOTREXATE WAY
- 2244798 RATIO-METHOTREXATE RPH
- 10mg Tablet
- 2182750 METHOTREXATE MAY
MITOTANE
- 500mg Tablet
- 463221 LYSODREN BMS
NILUTAMIDE
- 50mg Tablet
- 2221861 ANANDRON SAC
PROCARBAZINE HCL
- 50mg Capsule
- 12750 NATULAN SIG
RITUXIMAB
Limited use benefit (prior approval required).
Prescribed by a rheumatologist for treatment of adult patients with severely active rheumatoid arthritis who have failed to respond to a trial of an anti-TNF agent. Treatment should be combined with methotrexate. Rituximab should not be used in combination with anti-TNF agents.
Treatment beyond six months will only be considered for patients who have achieved a response. (Please refer to Appendix A).
- 10mg/mL Injection
- 2241927 RITUXAN HLR
SUNITINIB MALATE
Limited use benefit (Prior approval required)
Criteria for initial six month coverage of Sutent:
For patients with histologically proven unresectable or recurrent/metastatic GIST who have failed or are unable to tolerate imatinib therapy. Sunitinib will not be funded concomitantly with imatinib.
Criteria for assessment at every six months:
There is no objective evidence of disease progression.
- 12.5mg Capsule
- 2280795 SUTENT PFI
- 25mg Capsule
- 2280809 SUTENT PFI
- 50mg Capsule
- 2280817 SUTENT PFI
TAMOXIFEN CITRATE
- 10mg Tablet
- 812404 APO-TAMOX APX
- 2088428 GEN-TAMOXIFEN GEN
- 851965 NOVO-TAMOXIFEN NOP
- 2237459 PMS-TAMOXIFEN PMS
- 1926624 TAMOFEN SAC
- 2296721 TAMOXIFEN PDL
- 20mg Tablet
- 812390 APO-TAMOX APX
- 2089858 GEN-TAMOXIFEN GEN
- 2048485 NOLVADEX D AZC
- 851973 NOVO-TAMOXIFEN NOP
- 2237460 PMS-TAMOXIFEN PMS
- 1926632 TAMOFEN SAC
- 2296748 TAMOXIFEN PDL
TEMOZOLOMIDE
Limited use benefit (prior approval required).
For:
- treatment of adult patients with glioblastoma multiforme or anaplastic astrocytoma, and documented evidence of recurrence or progression after standard therapy (resection, radiotherapy, and chemotherapy).
- treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment.
- 5mg Capsule
- 2241093 TEMODAL SCH
- 20mg Capsule
- 2241094 TEMODAL SCH
- 100mg Capsule
- 2241095 TEMODAL SCH
- 250mg Capsule
- 2241096 TEMODAL SCH
THIOGUANINE
- 40mg Tablet
- 282081 LANVIS GSK
TRETINOIN
- 10mg Capsule
- 2145839 VESANOID HLR
TRIPTORELIN PAMOATE
- 3.75mg/Vial Injection
- 2240000 TRELSTAR WAT
- 11.25mg/Vial Injection
- 2243856 TRELSTAR LA WAT
VINCRISTINE SULFATE
- 1mg/mL Injection
- 2143305 VINCRISTINE SULFATE NOP
- 2183013 VINCRISTINE SULFATE MAY